FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

NCT00323011 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped drug not available

Conditions

Colorectal Cancer

Interventions

DRUG: Fragmin, 5-Fluorouracil, Folinic Acid, irinotecan, bevacizumab

Sponsor

University of Southern California

Collaborators

[object Object]